Impact Factor
3.71
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.86
763 total citations
h5-index
31
h5 depth signal
Cited share
87.4%
180 of 206
Total citations
763
Citation footprint
Metric signal
3.36
External metric anchor
Self-citation
2.9%
22 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
305
Italy
193
United Kingdom
160
China
102
Spain
91
Citing Fields of Research
Allergies
422
Respiratory Support
336
Lung Cancer
209
Auto-Inflammatory Disorders
136
Cystic Fibrosis
114
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,991
Articles tracked across the journal lifetime
Indexed publication set
206
180 cited publications
Last 12 months
104
8.7 publications/month
Open access share
22.1%
23 OA publications in the last year
Leading citing country
United States
305 citing publications
Leading citing field
Allergies
422 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Feb. 2010-
v4n1, Feb. 2010-
Research Focus & Classification
Indexed Subjects
Allergies
Respiratory Support
Lung Cancer
Auto-Inflammatory Disorders
Cystic Fibrosis
Broad Categories
Pulmonary Medicine
Allergies
Lung Cancer
Auto-Inflammatory Disorders
Respiratory Support
Virology
MeSH Descriptors
Respiratory Tract Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/17476348.2026.2749889
Open DOI
Heat and childhood respiratory health: exploring the evidence and raising the red flags
Climate change impacts on the health of vulnerable groups globally. Heat, as a specific component of climate change, affects the respiratory health of children, particularly those from marginalized communities and in low and middle-incom...
02
DOI 10.1080/17476348.2026.2744440
Open DOI
Ki-67 antigen in lung carcinoids/neuroendocrine tumors: from a proliferation marker to a clinical compass
03
DOI 10.1080/17476348.2026.2744435
Open DOI
Preserved ratio impaired spirometry: implications for clinical practice
1. Preserved ratio impaired spirometry (PRISm), defined as a reduced percentage of predicted forced expiratory volume in 1 s (FEV1) <80% post-bronchodilatation with a normal FEV1/forced vital capac...
04
DOI 10.1080/17476348.2026.2740205
Open DOI
Pulmonary black carbon accumulation: mechanisms, health impacts, and environmental sources
05
DOI 10.1080/17476348.2026.2736889
Open DOI
Updates in the diagnosis of interstitial lung disease: evolving concepts and terminology
06
DOI 10.1080/17476348.2026.2738234
Open DOI
Alternatives to positive airway pressure devices for obstructive sleep apnea: a phenotype-guided review
1. Obstructive sleep apnea (OSA) is among the most prevalent chronic disorders in adult medicine, with contemporary estimates indicating a global burden of nearly one billion adults aged 30–69 year...
07
DOI 10.1080/17476348.2026.2739660
Open DOI
Methacholine challenge positivity and FEV1/FVC change at clinically determined follow-up
08
DOI 10.1080/17476348.2026.2736322
Open DOI
The role of air quality and pollution in obstructive sleep apnea: insights from recent studies
1. The prevalence of obstructive sleep apnea (OSA) has accelerated, with 32.4% of American adults affected in 2024 [1]. Other studies estimated OSA prevalence ranged from 9% to 38% [2,3]. Untreated...
09
DOI 10.1080/17476348.2026.2736890
Open DOI
Exploring climate, air pollution, and respiratory disease hospitalizations in Brazil: a scoping review
1. According to the sixth State of Global Air report, air pollution is the leading environmental risk factor for mortality worldwide, contributing to 7.9 million deaths in 2023. The most severe hea...
10
DOI 10.1080/17476348.2026.2730537
Open DOI
Association of GLP-1–based therapy with asthma-related outcomes in patients with obesity: a propensity-matched retrospective cohort study
Obesity worsens asthma morbidity, but observational associations between glucagon-like peptide-1 (GLP-1)-based therapy and respiratory outcomes may be confounded by treatment selection. We conducted an active-comparator retrospective coh...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.